Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew McPartlin

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2022
Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal CancerJames M Price, Hitesh B Mistry, Guy Betts, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2026
Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomesJohn Mohan Mathew, Hannah Bacon, Jeff Winter, et al.
The British Journal of Radiology|December 18, 2019
Inter-fraction robustness of intensity-modulated proton therapy in the post-operative treatment of oropharyngeal and oral cavity squamous cell carcinomasChristina Hague, Marianne Aznar, Lei Dong, et al.
Oral Oncology|May 13, 2026
Impact of metastasis-directed therapy for metachronous thoracic metastases following definitive (chemo)radiotherapy in p16-positive head and neck squamous cell carcinomaSophia Ly, Alexander Rühle, Scott Bratman, et al.
Head & Neck|October 30, 2024
Impact of Postoperative Neck Radiotherapy Volumes on Long-Term Unstimulated Saliva Flow Following Primary Surgery and Ipsilateral Neck Dissection for Oral Cavity Squamous Cell CarcinomaClaire M Rooney, Shao Hui Huang, Jie Su, et al.
Oral Oncology|August 22, 2024
The prognostic value of image-identified extranodal extension in laryngeal and hypopharyngeal carcinoma following definitive (chemo-)radiotherapySulaiman Alsheikh, Jie Su, Brian O'Sullivan, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2025
Prevalence and Prognostic Value of Individual T4-defining Radiologic Features in HPV-Positive Oropharyngeal CarcinomaMohd Hafiz Johari, Alexander Rühle, Jie Su, et al.
Oral Oncology|April 18, 2025
Factors associated with detection of oligometastatic recurrence and outcome following definitive (Chemo)radiotherapy for oropharyngeal carcinomaRevadhi C Chelvarajah, Ye Liu, Jie Su, et al.
The Laryngoscope|February 7, 2026
Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRTAlexander Rühle, Ranjan Subramani, Jie Su, et al.
Oral Oncology|November 23, 2025
Outcomes and characteristics of patients receiving pre-operative versus post-operative radiotherapy for sinonasal squamous cell carcinomaRevadhi C Chelvarajah, Shao Hui Huang, Jie Su, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2022
Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal CancerJames M Price, Hitesh B Mistry, Guy Betts, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2026
Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomesJohn Mohan Mathew, Hannah Bacon, Jeff Winter, et al.
The British Journal of Radiology|December 18, 2019
Inter-fraction robustness of intensity-modulated proton therapy in the post-operative treatment of oropharyngeal and oral cavity squamous cell carcinomasChristina Hague, Marianne Aznar, Lei Dong, et al.
Oral Oncology|May 13, 2026
Impact of metastasis-directed therapy for metachronous thoracic metastases following definitive (chemo)radiotherapy in p16-positive head and neck squamous cell carcinomaSophia Ly, Alexander Rühle, Scott Bratman, et al.
Head & Neck|October 30, 2024
Impact of Postoperative Neck Radiotherapy Volumes on Long-Term Unstimulated Saliva Flow Following Primary Surgery and Ipsilateral Neck Dissection for Oral Cavity Squamous Cell CarcinomaClaire M Rooney, Shao Hui Huang, Jie Su, et al.
Oral Oncology|August 22, 2024
The prognostic value of image-identified extranodal extension in laryngeal and hypopharyngeal carcinoma following definitive (chemo-)radiotherapySulaiman Alsheikh, Jie Su, Brian O'Sullivan, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2025
Prevalence and Prognostic Value of Individual T4-defining Radiologic Features in HPV-Positive Oropharyngeal CarcinomaMohd Hafiz Johari, Alexander Rühle, Jie Su, et al.
Oral Oncology|April 18, 2025
Factors associated with detection of oligometastatic recurrence and outcome following definitive (Chemo)radiotherapy for oropharyngeal carcinomaRevadhi C Chelvarajah, Ye Liu, Jie Su, et al.
The Laryngoscope|February 7, 2026
Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRTAlexander Rühle, Ranjan Subramani, Jie Su, et al.
Oral Oncology|November 23, 2025
Outcomes and characteristics of patients receiving pre-operative versus post-operative radiotherapy for sinonasal squamous cell carcinomaRevadhi C Chelvarajah, Shao Hui Huang, Jie Su, et al.
Pageof 6